Garcia-Romeu A - Search Results

1

Classic psychedelics in the treatment of substance use disorder: Potential synergies with twelve-step programs.

Yaden DB, Berghella AP, Regier PS, Garcia-Romeu A, Johnson MW, Hendricks PS. Yaden DB, et al. Int J Drug Policy. 2021 Dec;98:103380. doi: 10.1016/j.drugpo.2021.103380. Epub 2021 Jul 27. Int J Drug Policy. 2021. PMID: 34329952 Review.

2

Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction.

Johnson MW, Garcia-Romeu A, Cosimano MP, Griffiths RR. Johnson MW, et al. J Psychopharmacol. 2014 Nov;28(11):983-92. doi: 10.1177/0269881114548296. Epub 2014 Sep 11. J Psychopharmacol. 2014. PMID: 25213996 Free PMC article. Clinical Trial.

3

Psilocybin-occasioned mystical experiences in the treatment of tobacco addiction.

Garcia-Romeu A, Griffiths RR, Johnson MW. Garcia-Romeu A, et al. Curr Drug Abuse Rev. 2014;7(3):157-64. doi: 10.2174/1874473708666150107121331. Curr Drug Abuse Rev. 2014. PMID: 25563443 Free PMC article. Clinical Trial.

4

Long-term follow-up of psilocybin-facilitated smoking cessation.

Johnson MW, Garcia-Romeu A, Griffiths RR. Johnson MW, et al. Am J Drug Alcohol Abuse. 2017 Jan;43(1):55-60. doi: 10.3109/00952990.2016.1170135. Epub 2016 Jul 21. Am J Drug Alcohol Abuse. 2017. PMID: 27441452 Free PMC article. Clinical Trial.

5

An online survey of tobacco smoking cessation associated with naturalistic psychedelic use.

Johnson MW, Garcia-Romeu A, Johnson PS, Griffiths RR. Johnson MW, et al. J Psychopharmacol. 2017 Jul;31(7):841-850. doi: 10.1177/0269881116684335. Epub 2017 Jan 18. J Psychopharmacol. 2017. PMID: 28095732 Free PMC article.

6

Psychedelic therapy for smoking cessation: Qualitative analysis of participant accounts.

Noorani T, Garcia-Romeu A, Swift TC, Griffiths RR, Johnson MW. Noorani T, et al. J Psychopharmacol. 2018 Jul;32(7):756-769. doi: 10.1177/0269881118780612. Epub 2018 Jun 25. J Psychopharmacol. 2018. PMID: 29938565

7

Cessation and reduction in alcohol consumption and misuse after psychedelic use.

Garcia-Romeu A, Davis AK, Erowid F, Erowid E, Griffiths RR, Johnson MW. Garcia-Romeu A, et al. J Psychopharmacol. 2019 Sep;33(9):1088-1101. doi: 10.1177/0269881119845793. Epub 2019 May 14. J Psychopharmacol. 2019. PMID: 31084460

8

Persisting Reductions in Cannabis, Opioid, and Stimulant Misuse After Naturalistic Psychedelic Use: An Online Survey.

Garcia-Romeu A, Davis AK, Erowid E, Erowid F, Griffiths RR, Johnson MW. Garcia-Romeu A, et al. Front Psychiatry. 2020 Jan 22;10:955. doi: 10.3389/fpsyt.2019.00955. eCollection 2019. Front Psychiatry. 2020. PMID: 32038317 Free PMC article.

9

Optimal dosing for psilocybin pharmacotherapy: Considering weight-adjusted and fixed dosing approaches.

Garcia-Romeu A, Barrett FS, Carbonaro TM, Johnson MW, Griffiths RR. Garcia-Romeu A, et al. J Psychopharmacol. 2021 Apr;35(4):353-361. doi: 10.1177/0269881121991822. Epub 2021 Feb 20. J Psychopharmacol. 2021. PMID: 33611977 Free PMC article.

10

Set and Setting: A Randomized Study of Different Musical Genres in Supporting Psychedelic Therapy.

Strickland JC, Garcia-Romeu A, Johnson MW. Strickland JC, et al. ACS Pharmacol Transl Sci. 2020 Dec 29;4(2):472-478. doi: 10.1021/acsptsci.0c00187. eCollection 2021 Apr 9. ACS Pharmacol Transl Sci. 2020. PMID: 33860177 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

58 results

Search Page

Filters